BIOSTATISTICS AND DATA MANAGEMENT SECTION

生物统计和数据管理部分

• 批准号: 3853261
• 负责人: S M STEINBERG
• 金额: --
• 依托单位: DIVISION OF CANCER TREATMENT
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3853261
• 关键词: AIDS; cancer information system; cancer registry /resource; clinical trials; computer data analysis; data collection; diagnosis design /evaluation; human therapy evaluation; model design /development; neoplasm /cancer diagnosis; neoplasm /cancer therapy; statistical service /center; statistics /biometry

The section is the statistical and data management component of the clinical oncology Program (COP). The section provides statistical leadership and data management consultation for major activities of the Program, and is involved in the design, conduct, monitoring, and statistical analyses of intramural and national multicenter clinical trials of experimental treatments for cancer, and intramural clinical trialb for treatment of AIDS. Other major collaborative efforts include studies to identify important prognostic and treatment selection factors, evaluate diagnostic procedures, develop improved staging systems, and assist investigators in the design, execution, and analyses of major in vitro drug testing studies. The Section develops new statistical designs and biometric methods related to the development and evaluation of new cancer and AIDS treatments. The Section maintains computerized data collection systems for intramural and national multicenter clinical protocols, and it works closely with interested branches to improve data recording and retrieval. The section is working to develop specialized clinical data bases for individual branches within the COP.

该科是统计和数据管理的组成部分， 临床肿瘤学计划（COP）。 本节提供了统计 主要活动的领导和数据管理咨询 计划，并参与设计，进行，监测， 校内和全国多中心临床研究的统计分析 癌症的实验性治疗试验， 试验用于治疗艾滋病。其他主要合作项目包括 确定重要预后和治疗选择的研究 因素，评估诊断程序，制定改进的分期 系统，并协助调查人员的设计，执行和分析 主要的体外药物测试研究。 科开发新的 统计设计和生物识别方法的发展和 评估新的癌症和艾滋病治疗方法。 该科认为， 计算机化数据收集系统， 多中心临床方案，它与感兴趣的 改进数据记录和检索。 该科 致力于为个人开发专门的临床数据库， COP内部的分支机构。